ArticleOncoTargets and therapy2016

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer.

Giuseppina Rosaria Rita Ricciardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.